Search research articles
Contact Us
Filters
Showing results (311-320 of 386) with videos related to
Page
of 39
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
Jeremie Calais, Wolfgang P Fendler, Matthias Eiber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
John Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
European Urology
|
December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
Cancer
|
May 2, 2019
Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection
David C Johnson, Jason J Yang, Lorna Kwan, et al.
Oncoimmunology
|
January 9, 2018
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
Saul J Priceman, Ethan A Gerdts, Dileshni Tilakawardane, et al.
JAMA Oncology
|
October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis
Amar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial
Ting Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Page
of 39
Search research articles
Search
Showing results (311-320 of 386) with videos related to
Sort By:
Page
of 39
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 16, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
Jeremie Calais, Wolfgang P Fendler, Matthias Eiber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
John Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
European Urology
|
December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
Wolfgang P Fendler, Justin Ferdinandus, Johannes Czernin, et al.
Cancer
|
May 2, 2019
Do contemporary imaging and biopsy techniques reliably identify unilateral prostate cancer? Implications for hemiablation patient selection
David C Johnson, Jason J Yang, Lorna Kwan, et al.
Oncoimmunology
|
January 9, 2018
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
Saul J Priceman, Ethan A Gerdts, Dileshni Tilakawardane, et al.
JAMA Oncology
|
October 17, 2018
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis
Amar U Kishan, Xiaoyan Wang, Wendy Seiferheld, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2022
Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial
Ting Martin Ma, Leslie K Ballas, Holly Wilhalme, et al.
Molecular Cancer Research : MCR
|
March 29, 2019
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity
Rahul R Aggarwal, David A Quigley, Jiaoti Huang, et al.
Journal of the National Cancer Institute
|
December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Page
of 39